Supplementation with β-1,3–1,6-D-glucan to dogs with IBD reduces Canine Inflammatory Bowel Disease Activity Index (CIBDAI) values, increases levels of the anti-inflammatory cytokine interleukin (IL)-10, and improves histopathological parameters [20]. Here, IL10 is linked to inflammatory bowel disease.